Home » Topics » Respiratory, BioWorld Science

Respiratory, BioWorld Science
RSS

Glenmark submits NDA for Ryaltris for seasonal allergic rhinitis

May 22, 2018

Genentech presents first phase I data for BITS-7201A

May 22, 2018

Phase III GALATHEA trial of Fasenra in COPD does not meet primary endpoint

May 11, 2018

INTEREST study of Traumakine in ARDS does not meet primary efficacy composite endpoint

May 8, 2018

RTI International discovers new APLNR agonists

May 4, 2018

Patient enrollment ongoing in phase I study of CSJ-117 in atopic asthma

May 3, 2018

Vertex initiates phase III studies of VX-445, tezacaftor and ivacaftor in cystic fibrosis

April 27, 2018

AbbVie, Galapagos discover new CFTR modulators

April 27, 2018

FDA approves expanded indication for Trelegy Ellipta in COPD

April 25, 2018

Galapagos initiates clinical trial with triple combination therapy in cystic fibrosis

April 25, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 27, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 27, 2025
Abbvie and Simcere enter a $1B T-cell engager deal
BioWorld Asia
Abbvie Inc. and Simcere Zaiming Pharmaceutical Co. Ltd. are part of the volley of large deals accompanying the opening of the 43rd annual J.P. Morgan Healthcare...
In monkeys, enhanced TB vaccine dissolves after inducing protection
BioWorld Science
An experimental tuberculosis (TB) vaccine with a dual mission – self-destruction after inducing immunity – improved the design of the Bacillus Calmette-Guérin...
New drugs with the same old resistance tricks?
BioWorld
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in 2020. And figures are rising, with...